Janux Therapeutics Inc
NASDAQ:JANX 3:06:49 PM EDT
| Market Cap (Intraday) | 475.83M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $10.93 |
| 50-Day MA | $12.71 |
| 200-Day MA | $19.02 |
Janux Therapeutics Inc Stock, NASDAQ:JANX
11099 North Torrey Pines Park, Suite 290, La Jolla, California 92037
United States of America
Phone: +1.858.750.4700
Number of Employees: 33
Description
Janux Therapeutics, Inc. operates preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in La Jolla, CA.